// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Change in crackle characteristics among male adult smokers

Siwimon Kaju - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Frequency of cough versus dyspnoea as the first recorded symptom of idiopathic pulmonary fibrosis

David Thickett - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Idiopathic pulmonary fibrosis

N/A

AKT1/AKT2 mRNA Balance Is Significantly Different In IPF BAL Cells Compared To Other Fibrotic ILDs.

E Tsitoura - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary fibrosis

miR155

Atypical presentation of a rare lung condition: axillary and paraspinal lymphadenopathy in a patient with clinical and radiological features of lymphangioleomatosis (LAM)

Ajikumar Kavidasan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Allopurinol reduces RV mass in patients with severe COPD

Patrick Liu Shiu Cheong - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Allopurinol

Hypoxia and cardiovascular comorbidity in the ESADA OSA patients with insomnia symptoms

Ulla Anttalainen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Insomnia

N/A

Description of the UK’s asthma and COPD inhaler use

Chloe Bloom - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Early life exposome and lung function in children from the HELIX cohort

Valerie Siroux - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

HELIX syndrome

N/A

Association of Pre-miR-rs2910164 polymorphism with non-small cell lung cancer in an Iranian population

Neda K. Dezfoli - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Patient views on new technologies to assist in the management of chronic cough

Bashar Al-Sheklly - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The effect of early puberty on asthma in women and men: A Mendelian randomization study

Cosetta Minelli - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Precocious puberty

N/A

Can bronchoscopy be made safer through team-based Simulation?

James Tonkin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Should we treat every patient with latent TB? Is there a cost to pay?

Usman Maqsood - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incidence of airflow obstruction over 20 years in Europe

Simone Accordini - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review

Dayle Terrington - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sarcoidosis

N/A

Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells

Andrew Higham - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Budesonide

A survey examining Mechanical Insufflation-Exsufflation use in UK, adult intensive care units.

Ema Swingwood - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

COPD exacerbation phenotypes in a five year hospitalisation cohort

Simon Brill - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Utility of drug reaction assessments for inhaled therapies in patients with chronic suppurative lung diseases: results from 5 years of drug reaction assessments

Giulia Rinaldi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does the sonographic presence and severity of pleural fluid septation have an impact on clinical outcomes in pleural infection? - Data from the Pleural Infection Longitudinal Outcome Study (PILOT)

John Corcoran - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved